DOCSLIB.ORG

Public Statement on the Use of Herbal

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Public Statement on the Use of Herbal 1 8 July 2020 2 EMA/HMPC/893108/2011 Rev. 1 3 Committee on Herbal Medicinal Products (HMPC) 1 4 Public statement on the use of herbal medicinal products 5 containing toxic, unsaturated pyrrolizidine alkaloids (PAs) 6 including recommendations regarding contamination of 7 herbal medicinal products with pyrrolizidine alkaloids 8 Draft Draft discussed by Working Party on Community monographs and November 2011 Community list (MLWP) January 2012 March 2012 May 2012 Adopted by Committee on Herbal Medicinal Products (HMPC) for 24 September 2012 release for consultation Start of public consultation 25 October 2012 End of consultation (deadline for comments) 15 February 2013 2nd draft discussed by MLWP March 2013 May 2013 July 2013 Coordination with Safety Working Party July-October 2013 2nd draft adopted by HMPC for release for consultation 17 September 2013 End of consultation (deadline for comments) 15 February 2014 Re-discussion by MLWP of 2nd draft March 2014 October 2014 Adopted by HMPC 24 November 2014 Draft Revision 1 discussed in HMPC November 2019 January 2020 1 In the context of this PS, the term "herbal medicinal products" (HMP) also includes "traditional herbal medicinal products" (THMP). Therefore only the term "herbal medicinal products" or "HMP" is used throughout. Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 An agency of the European Union © European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged. March 2020 May 2020 July 2020 Draft Revision 1 adopted by HMPC for release for consultation 8 July 2020 Start of public consultation 15 August 2020 End of consultation (deadline for comments). Comments should be 15 November 2020 provided using this template. The completed comments form should be sent to [email protected] 9 Keywords Herbal medicinal products; Traditional herbal medicinal products; HMPC; pyrrolizidine alkaloids 10 Public statement on the use of herbal medicinal products containing toxic, unsaturated pyrrolizidine alkaloids (PAs) including recommendations regarding contamination of herbal medicinal products with pyrrolizidine alkaloids EMA/HMPC/893108/2011 Page 2/39 11 Public statement on the use of herbal medicinal products 12 containing toxic, unsaturated pyrrolizidine alkaloids (PAs) 13 including recommendations regarding contamination of 14 herbal medicinal products with PAs 15 Table of contents 16 1. Introduction (Problem statement) .......................................................... 4 17 1.1. Occurrence of pyrrolizidine alkaloids (PAs) ............................................................. 4 18 1.2. Chemistry and types of PAs ................................................................................. 4 19 1.3. Human exposure to PAs via food .......................................................................... 6 20 1.4. Contamination of herbal medicinal products ........................................................... 9 21 2. Discussion ............................................................................................... 9 22 2.1. Regulatory status and assessment of PAs or PA-containing products .......................... 9 23 2.2. Pharmacokinetics of PAs .................................................................................... 11 24 2.3. Mechanism of toxic action of PAs ........................................................................ 14 25 2.3.1. Single and repeat dose toxicity in animals ......................................................... 15 26 2.3.2. Acute and chronic toxicity in humans ............................................................... 17 27 2.3.3. Genotoxicity and Carcinogenicity of PAs ............................................................ 19 28 3. Conclusions and recommendations ........................................................ 23 29 3.1. Intake limits .................................................................................................... 23 30 3.2. Recommendations ............................................................................................ 24 31 3.3. Quality measures to reduce contamination with PAs .............................................. 26 32 4. Implementation of suitable testing procedures to control PA levels ...... 26 33 4.1. Analytical methods ........................................................................................... 26 34 4.2. Specifications for herbal substances, herbal preparations, HMPs .............................. 27 35 4.3. Implementation of measures to avoid or reduce PA contamination in HMPs ............... 27 36 5. Abbreviations ........................................................................................ 28 37 6. References ............................................................................................ 29 Public statement on the use of herbal medicinal products containing toxic, unsaturated pyrrolizidine alkaloids (PAs) including recommendations regarding contamination of herbal medicinal products with pyrrolizidine alkaloids EMA/HMPC/893108/2011 Page 3/39 38 1. Introduction (Problem statement) 39 It became apparent during assessment of Symphytum officinale (monograph 40 EMEA/HMPC/572844/2009) that the risk assessment of pyrrolizidine alkaloids (PAs) poses considerable 41 difficulties, with several PAs being regarded as both hepatotoxic and carcinogenic. Considering that PAs 42 are natural constituents of a number of plants used for medicinal purposes the HMPC decided to 43 prepare a public statement on the use of herbal preparations containing PAs (EMA 2014). 44 Furthermore, it was increasingly reported that herbal teas including those used as medicines may 45 contain variable amounts of PAs, although the plants used as ingredients are not known to produce 46 PAs (BfR 2013). In the following, based on information from several Member States, it was recognised 47 that there might be a problem of contamination due to PA-containing weeds, which has to be seen 48 primarily as quality-related topic. Several national regulatory authorities addressed the issue of PA 49 contamination in HMPs and also the HMPC prepared a statement to support harmonisation in this 50 regard (EMA 2016). The Public statement on contamination of herbal medicinal products/traditional 51 herbal medicinal products with pyrrolizidine alkaloids (EMA/HMPC/328782/2016) gave transitional 52 recommendations for risk management and quality control. 53 After a 3-years-period, the HMPC decided to reconsider both Public statements (see HMPC meeting 54 report January 2019 - EMA/HMPC/26549/2019) and published Calls for data before re-assessing and 55 concluding on recommendations with respect to the risks associated with the use of herbal medicinal 56 products containing PAs naturally or from contamination. 57 Revision 1 is based on a review of newly available data and the improved evaluation methods. The 58 specific contamination issue and subsequent recommendations for risk management and quality 59 control are now included (see also section 1.4; 1.4; 3.2 and 4). 60 1.1. Occurrence of pyrrolizidine alkaloids (PAs) 61 Pyrrolizidine alkaloids are heterocyclic organic compounds derived from ornithine (Moreira et al. 2018). 62 They occur in nature in more than 6,000 plants (in excess of 300 plant species of up to 13 families, 63 mainly in the families of Boraginaceae (all genera), Asteraceae (tribes Senecioneae and Eupatorieae) 64 and Fabaceae (genus Crotalaria)), representing about 3% of the world’s flowering plants (Prakash et 65 al. 1999, Louisse et al. 2019, He et al. 2019). They are very effective insect-feeding deterrents and 66 consequently have evolved independently on at least four occasions in a number of different plant 67 families (Edgar et al. 2015). More than 350 different PAs, excluding the N-Oxides, were described up 68 to now and it is assumed that about half of them are hepatotoxic (Fu et al. 2004; He et al. 2019). 69 Both, composition and concentration of PAs may fluctuate and depend on various factors such as 70 species, age and part of the plant, variety (genotype/chemotype), season, location etc. (Hoogenboom 71 et al. 2011; Bodi et al. 2014). Thus, all known PAs of a PA-containing plant are not necessarily present 72 at the same time. The same species growing in different locations or in different seasons may contain 73 different alkaloids (Mattocks 1986, Flade et al. 2019). The toxins are commonly concentrated in the 74 seeds and the flowering parts of the plant, with decreasing amounts in the leaves, stems and roots. 75 Most plants produce mixtures of PAs in varying concentrations ranging from less than 0.001% to 5% 76 (up to 19% based on dry weight) in certain plant seeds. Reported concentrations vary from trace 77 amounts up to 19% based on dry weight (EFSA 2011, Bodi et al. 2014). 78 1.2. Chemistry and types of PAs 79 Most PAs are esters of hydroxylated 1-methylpyrrolizidines. The basic components, called necines, are 80 derived from bicyclic amino alcohols that, in turn, are derived from the polyamines putrescine and Public statement on the use of herbal medicinal products containing toxic, unsaturated pyrrolizidine alkaloids (PAs) including recommendations regarding contamination of herbal medicinal products with pyrrolizidine alkaloids EMA/HMPC/893108/2011 Page 4/39 81 spermidine via the
Load more

Recommended publications
  • Phenological Responses to Climate in the Alberta Native Flora: Herbarium Specimens Reveal Differential Responsiveness Between Species in Mesic and Xeric Habitats
    University of Calgary PRISM: University of Calgary's Digital Repository Graduate Studies The Vault: Electronic Theses and Dissertations 2019-03-01 Phenological responses to climate in the Alberta native flora: Herbarium specimens reveal differential responsiveness between species in mesic and xeric habitats Porto, Cassiano Porto, C. (2019). Phenological responses to climate in the Alberta native flora: Herbarium specimens reveal differential responsiveness between species in mesic and xeric habitats (Unpublished master's thesis). University of Calgary, Calgary, AB. http://hdl.handle.net/1880/109929 master thesis University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. Downloaded from PRISM: https://prism.ucalgary.ca UNIVERSITY OF CALGARY Phenological responses to climate in the Alberta native flora: Herbarium specimens reveal differential responsiveness between species in mesic and xeric habitats by Cassiano Porto A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE GRADUATE PROGRAM IN BIOLOGICAL SCIENCES CALGARY, ALBERTA MARCH, 2019 © Cassiano Porto 2019 UNIVERSITY OF CALGARY Phenological responses to climate in the Alberta native flora: Herbarium specimens reveal differential responsiveness between species in mesic and xeric habitats by Cassiano Porto A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE GRADUATE PROGRAM IN BIOLOGICAL SCIENCES Research Supervisor: Dr.
    [Show full text]
  • Report of the Advisory Group to Recommend Priorities for the IARC Monographs During 2020–2024
    IARC Monographs on the Identification of Carcinogenic Hazards to Humans Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 CONTENTS Introduction ................................................................................................................................... 1 Acetaldehyde (CAS No. 75-07-0) ................................................................................................. 3 Acrolein (CAS No. 107-02-8) ....................................................................................................... 4 Acrylamide (CAS No. 79-06-1) .................................................................................................... 5 Acrylonitrile (CAS No. 107-13-1) ................................................................................................ 6 Aflatoxins (CAS No. 1402-68-2) .................................................................................................. 8 Air pollutants and underlying mechanisms for breast cancer ....................................................... 9 Airborne gram-negative bacterial endotoxins ............................................................................. 10 Alachlor (chloroacetanilide herbicide) (CAS No. 15972-60-8) .................................................. 10 Aluminium (CAS No. 7429-90-5) .............................................................................................. 11
    [Show full text]
  • Clinical Biochemistry of Hepatotoxicity
    linica f C l To o x l ic a o n r l o u g Singh, J Clinic Toxicol 2011, S:4 o y J Journal of Clinical Toxicology DOI: 10.4172/2161-0495.S4-001 ISSN: 2161-0495 ReviewResearch Article Article OpenOpen Access Access Clinical Biochemistry of Hepatotoxicity Anita Singh1, Tej K Bhat2 and Om P Sharma2* 1CSK Himachal Pradesh, Krishi Vishva Vidyalaya, Palampur (HP) 176 062, India 2Biochemistry Laboratory, Indian Veterinary Research Institute, Regional Station, Palampur (HP) 176 061, India Abstract Liver plays a central role in the metabolism and excretion of xenobiotics which makes it highly susceptible to their adverse and toxic effects. Liver injury caused by various toxic chemicals or their reactive metabolites [hepatotoxicants) is known as hepatotoxicity. The present review describes the biotransformation of hepatotoxicants and various models used to study hepatotoxicity. It provides an overview of pathological and biochemical mechanism involved during hepatotoxicity together with alteration of clinical biochemistry during liver injury. The review has been supported by a list of important hepatotoxicants as well as common hepatoprotective herbs. Keywords: Hepatotoxicity; Hepatotoxicant; In Vivo models; In Vitro production of bile thus leading to the body’s inability to flush out the models; Pathology; Alanine aminotransferase; Alkaline phosphatase; chemicals through waste. Smooth endoplasmic reticulum of the liver is Bilirubin; Hepatoprotective the principal ‘metabolic clearing house’ for both endogenous chemicals like cholesterol, steroid hormones, fatty acids and proteins, and Introduction exogenous substances like drugs and alcohol. The central role played by liver in the clearance and transformation of chemicals exposes it to Hepatotoxicity refers to liver dysfunction or liver damage that is toxic injury [4].
    [Show full text]
  • WRITTEN FINDINGS of the WASHINGTON STATE NOXIOUS WEED CONTROL BOARD 2018 Noxious Weed List Proposal
    DRAFT: WRITTEN FINDINGS OF THE WASHINGTON STATE NOXIOUS WEED CONTROL BOARD 2018 Noxious Weed List Proposal Scientific Name: Tussilago farfara L. Synonyms: Cineraria farfara Bernh., Farfara radiata Gilib., Tussilago alpestris Hegetschw., Tussilago umbertina Borbás Common Name: European coltsfoot, coltsfoot, bullsfoot, coughwort, butterbur, horsehoof, foalswort, fieldhove, English tobacco, hallfoot Family: Asteraceae Legal Status: Proposed as a Class B noxious weed for 2018, to be designated for control throughout Washington, except for in Grant, Lincoln, Adams, Benton, and Franklin counties. Images: left, blooming flowerheads of Tussilago farfara, image by Caleb Slemmons, National Ecological Observatory Network, Bugwood.org; center, leaves of T. farfara growing with ferns, grasses and other groundcover species; right, mature seedheads of T. farfara before seeds have been dispersed, center and right images by Leslie J. Mehrhoff, University of Connecticut, Bugwood.org. Description and Variation: The common name of Tussilago farfara, coltsfoot, refers to the outline of the basal leaf being that of a colt’s footprint. Overall habit: Tussilago farfara is a rhizomatous perennial, growing up to 19.7 inches (50 cm tall), which can form extensive colonies. Plants first send up flowering stems in the spring, each with a single yellow flowerhead. Just before or after flowers have formed seeds, basal leaves on long petioles grow from the rhizomes, with somewhat roundish leaf blades that are more or less white-woolly on the undersides. Roots: Plants have long creeping, white scaly rhizomes (Griffiths 1994, Chen and Nordenstam 2011). Rhizomes are branching and have fibrous roots (Barkley 2006). They are also brittle and can break easily (Pfeiffer et al.
    [Show full text]
  • National Center for Toxicological Research
    National Center for Toxicological Research Annual Report Research Accomplishments and Plans FY 2015 – FY 2016 Page 0 of 193 Table of Contents Preface – William Slikker, Jr., Ph.D. ................................................................................... 3 NCTR Vision ......................................................................................................................... 7 NCTR Mission ...................................................................................................................... 7 NCTR Strategic Plan ............................................................................................................ 7 NCTR Organizational Structure .......................................................................................... 8 NCTR Location and Facilities .............................................................................................. 9 NCTR Advances Research Through Outreach and Collaboration ................................... 10 NCTR Global Outreach and Training Activities ............................................................... 12 Global Summit on Regulatory Science .................................................................................................12 Training Activities .................................................................................................................................14 NCTR Scientists – Leaders in the Research Community .................................................. 15 Science Advisory Board ...................................................................................................
    [Show full text]
  • CHEMICAL PRODUCTS CORPORATION April 20, 2018 Via
    CHEMICAL PRODUCTS CORPORATION CARTERSVILLE, GEORGIA 30120 POST OFFICE BOX 2470 TELEPHONE 770-382-2144 FAX 770-386-6053 April 20, 2018 Via Certified Mail and Electronic Mail ([email protected]) USEPA Headquarters William Jefferson Clinton Federal Building 1200 Pennsylvania Avenue, NW Mail Code: 2821T Washington, DC 20460 Subject: Information Quality Guidelines (IQG) identifier: RFC #17003 Additional Information demonstrating that National Toxicology Program Technical Report 494 should not be the basis for provisional screening values presented in Appendix A of “Provisional Peer-Reviewed Toxicity Values for 9,10- Anthraquinone (CASRN 84-65-1)”, EPA/690/R-11/007F, Final 2-17-2011 or the screening levels for “Anthraquinone, 9,10-” in EPA’s Regional Screening Level Tables Dear Sir or Madam: This letter contains additional information to supplement the Request for Correction submitted by Chemical Products Corporation (CPC) on April 6, 2018, assigned Information Quality Guidelines Identifier RFC #17003. The contents of this letter provide yet another sufficient reason to conclude that the National Toxicology Program (NTP) peer review panel which accepted the conclusions presented in NTP Technical Report 494 (TR-494) were not presented accurate information, thus, the peer review panel was unable to render a sound scientific judgment regarding the conclusions presented in TR-494. The peer review of TR- 494 does not meet the “sound and objective scientific practices” REQUEST FOR CORRECTION SUBMITTED BY CHEMICAL PRODUCTS CORPORATION Additional Information IQG identifier: RFC #17003 Page 2 of 5 April 20, 2018 requirement contained in the EPA Guidelines and should not be accepted by EPA as a valid peer review.
    [Show full text]
  • THE ECOLOGICAL FEATURES of FLOWERS and INFLORESCENCES of TWO SPECIES of the GENUS Petasites Miller (ASTERACEAE)
    ACTA AGROBOTANICA Vol. 65 (2): 37–46 2012 THE ECOLOGICAL FEATURES OF FLOWERS AND INFLORESCENCES OF TWO SPECIES OF THE GENUS Petasites Miller (ASTERACEAE) Weronika Haratym, Elżbieta Weryszko-Chmielewska Department of Botany, University of Life Sciences in Lublin, Akademicka 15, 20-950 Lublin, Poland e-mail: [email protected] Received: 06.02.2012 Abstract The above-mentioned species are included The structural features of flowers and inflorescences of in bee plants (Bornus, 1989; Lipiń ski, 2010). Petasites hybridus and P. albus were compared. Only individu- Due to their flowering period (III-V), they can provide als producing flower heads with male flowers and few female a source of early spring pollen and nectar to insects flowers were found in the studied populations. Light microsco- which visit their flowers in large numbers under fa- py (LM) and scanning electron microscopy (SEM) were used vourable conditions. Many papers show that plant for examination. material obtained from their leaves and underground The present study shows that the stems of the above- parts (rhizomes, roots) has been used in herbalism -mentioned species differed in height and number of flower he- and medicine since ancient times (Podhajska and ads, but the number of flowers per head was similar. Larger flo- Rivola, 1992; Schaffner, 1996; Siegenha- wers were found on the stems of P. albus. The following features ler and Neuenschwander, 1996; Wildi et al. has been found to play an important role in pollination ecology: the strongly contrasting colours of the floral parts; on the petals, 1998). However, Smith and Culvenor (1981) the occurrence of several types of cells which can increase the as well as Sadowska (2004) note that P.
    [Show full text]
  • Hepatic Veno-Occlusive Disease As a Result of a Traditional Remedy: Confirmation of Toxic Pyrrolizidine Alkaloids As the Cause
    676 ORIGINAL ARTICLE J Clin Pathol: first published as 10.1136/jcp.55.9.676 on 1 September 2002. Downloaded from Hepatic veno-occlusive disease as a result of a traditional remedy: confirmation of toxic pyrrolizidine alkaloids as the cause, using an in vitro technique M Zuckerman, V Steenkamp, M J Stewart ............................................................................................................................. J Clin Pathol 2002;55:676–679 See end of article for Background/Aims: A child presented with hepatic veno-occlusive disease after having been adminis- authors’ affiliations tered a short course of treatment with a traditional herbal remedy. The child subsequently died. Post- ....................... mortem liver histology confirmed the diagnosis. This study aimed to investigate the hypothesis that the Correspondence to: herbal remedy was the cause of veno-occlusive disease. Dr M J Stewart, Department Methods: Extracts of the traditional remedy were analysed by colorimetry and gas chromatography/ of Chemical Pathology, mass spectrometry. Cultured hepatocytes were treated with an extract of the plant material and exam- University of the ined for morphological changes. Witwatersrand Medical Results: The screening analyses indicated the presence of toxic pyrrolizidine alkaloids, which were School, 7 York Road, Parktown 2193, Gauteng, later confirmed by gas chromatography/mass spectrometry. The cell studies indicated dose related South Africa; toxicity, with necrosis at high concentrations and apoptosis and abnormalities of the cytoskeleton at [email protected] lower concentrations. Accepted for publication 5 Conclusions: The simple screening techniques used allowed rapid confirmation of the presence of September 2001 toxic pyrrolizidines in the remedy. The in vitro method confirmed the toxicity of herbal extracts to hepa- ......................
    [Show full text]
  • WHMF123 Herbal Botany Last Modified: 16-Apr-2021
    SUBJECT OUTLINE Subject Name: Subject Code: Herbal Botany WHMF123 SECTION 1 – GENERAL INFORMATION Award/s: Total Course Credit Points: Level: Bachelor of Complementary Medicine 48 3rd Year Duration: 1 Semester Subject is: Elective Subject Credit Points: 2 Student Workload: No. timetabled hours per week: No. personal study hours per week: Total hours per week: 3 2 5 Delivery Mode*: ☐ On campus ☒ Online / Digital ☐ Blended ☐ Intensive Weekly Session^ Format/s - 1 session per week: ☒ eLearning modules: Lectures: Narrated PowerPoint presentations Tutorials: can include asynchronous tutor moderated discussion forum and activities, learning journal activities or other web-based resources *All modes are supported by the online learning management system which will include subject documents such as handouts, readings and assessment guides. ^A ‘session’ is made up of 3 hours of timetabled / online study time per week unless otherwise specified. Each subject has a set number of sessions as outlined above. Study Pattern: ☒ Full Time ☒ Part Time Pre-requisites: Nil Co-requisites: Nil SECTION 2 – ACADEMIC DETAILS Subject Rationale This foundational herbal medicine subject introduces students to the study of plant medicine via an exploration of botany. Through an understanding of basic plant morphology, botanical terminology, taxonomy, and nomenclature, students learn to recognise similar and different physical characteristics of plants and to identify plant specimens. Additionally students are introduced to the legislative and regulatory frameworks that govern the manufacture and sale of botanical medicines in Australia. Australian College of Natural Medicine Pty Ltd trading as Endeavour College of Natural Health, FIAFitnation (National CRICOS #00231G, RTO #31489) WHMF123 Herbal Botany Last modified: 16-Apr-2021 Version: 12.0 Page 1 of 5 Learning Outcomes 1.
    [Show full text]
  • Dioscorides De Materia Medica Pdf
    Dioscorides de materia medica pdf Continue Herbal written in Greek Discorides in the first century This article is about the book Dioscorides. For body medical knowledge, see Materia Medica. De materia medica Cover of an early printed version of De materia medica. Lyon, 1554AuthorPediaus Dioscorides Strange plants RomeSubjectMedicinal, DrugsPublication date50-70 (50-70)Pages5 volumesTextDe materia medica in Wikisource De materia medica (Latin name for Greek work Περὶ ὕλης ἰατρικῆς, Peri hul's iatrik's, both means about medical material) is a pharmacopeia of medicinal plants and medicines that can be obtained from them. The five-volume work was written between 50 and 70 CE by Pedanius Dioscorides, a Greek physician in the Roman army. It was widely read for more than 1,500 years until it supplanted the revised herbs during the Renaissance, making it one of the longest of all natural history books. The paper describes many drugs that are known to be effective, including aconite, aloe, coloxinth, colocum, genban, opium and squirt. In all, about 600 plants are covered, along with some animals and minerals, and about 1000 medicines of them. De materia medica was distributed as illustrated manuscripts, copied by hand, in Greek, Latin and Arabic throughout the media period. From the sixteenth century, the text of the Dioscopide was translated into Italian, German, Spanish and French, and in 1655 into English. It formed the basis of herbs in these languages by such people as Leonhart Fuchs, Valery Cordus, Lobelius, Rembert Dodoens, Carolus Klusius, John Gerard and William Turner. Gradually these herbs included more and more direct observations, complementing and eventually displacing the classic text.
    [Show full text]
  • TOX-27: Riddelliine (CASRN 23246-96-0)
    National Toxicology Program Toxicity Report Series Number 27 NTP Technical Report on Toxicity Studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344/N Rats and B6C3F1 Mice Po C. Chan, PhD, Study Scientist National Toxicology Program Post Office Box 12233 Research Triangle Park, NC 27709 NIH Publication 94-3350 December 1993 United States Department of Health and Human Services Public Health Service National Institutes of Health Note to the Reader The National Toxicology Program (NTP) is made up of four charter agencies of the United States Department of Health and Human Services (DHHS): • the National Cancer Institute (NCI) of the National Institutes of Health; • the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health; • the National Center for Toxicological Research (NCTR) of the Food and Drug Administration; and • the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control. In July 1981, the Carcinogenesis Bioassay Testing Program was transferred from NCI to NIEHS. NTP coordinates the relevant Public Health Service programs, staff, and resources that are concerned with basic and applied research and with biological assay development and validation. NTP develops, evaluates, and disseminates scientific information about potentially toxic and hazardous chemicals. This knowledge is used for protecting the health of the American people and for the primary prevention of disease. To carry out its mission, NTP designs and conducts studies to characterize and evaluate the toxicologic potential of selected chemicals in laboratory animals (usually two species, rats and mice). Chemicals selected for NTP toxicology studies are chosen primarily on the bases of human exposure, level of production, and chemical structure.
    [Show full text]
  • The Effect of Certain Plant Extracts Containing Pyrrolizidine Alkaloids on Lactuca Sativa Radicle Growth
    THE EFFECT OF CERTAIN PLANT EXTRACTS CONTAINING PYRROLIZIDINE ALKALOIDS ON LACTUCA SATIVA RADICLE GROWTH OANA-CRISTINA ŞEREMET*, O.T. OLARU**#, D. BĂLĂLĂU***, SIMONA NEGREŞ* * Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania ** Department of Botany and Cellular Biology, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania, #e-mail: [email protected] *** Department of Toxicology, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania Abstract: Pyrrolizidine alkaloids (PAs) are toxins synthesized by plants, known to be hepatotoxic, genotoxic and carcinogenic. Tussilago farfara (coltsfoot), Petasites hybridus (common butterbur), Senecio vernalis (eastern groundsel) and Symphytum officinale (comfrey) are species traditionally used in phytotherapy that besides the therapeutic compounds contain PAs. The total PAs and the corresponding N-oxides content of the solid plant extracts were measured using Ehrlich’s method with senecionine as a standard substance. The highest content of PAs was found in Senecio vernalis extract (424.92±9.81 mg%), followed by Symphytum officinale extract (150.24±10.35 mg%) and Petasites hybridus extract (0.021±0.00091 mg%). The lowest concentration was found in Tussilago farfara extract (0.0097±0.00072 mg%). In order to assess the toxicity of the extracts on Lactuca sativa, inhibitory concentrations 50% (IC50) of the root elongation were calculated. All extracts inhibited the elongation of the Lactuca sativa radicles. Senecio vernalis extract exhibited the highest toxicity, whilst Symphytum officinale extract, having the second highest concentration of PAs, has the highest IC50. Further studies should be performed in order to determine whether the inhibitory effect is due to the PAs content and how it is influenced by the other components of the extracts.
    [Show full text]